Caribou Biosciences (CRBU) Return on Sales (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Return on Sales data on file, last reported at 0.11% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.11%, up 7.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.12% (up 5.0% YoY), and the FY2025 annual result was 0.13%, up 2.0% from the prior year.
• Return on Sales fell to 0.11% in Q1 2026 per CRBU's latest filing, from 0.07% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q3 2023 and troughed at 0.19% in Q1 2024.
• A 5-year average of 0.12% and a median of 0.11% in 2023 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2024 and 2025: Return on Sales fell 18 bps in 2024, then advanced 11 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.08% in 2022, then dropped by 27 bps to 0.11% in 2023, then tumbled by 78 bps to 0.19% in 2024, then surged by 61 bps to 0.07% in 2025, then plunged by 52 bps to 0.11% in 2026.
• Business Quant data shows CRBU's Return on Sales at 0.11% in Q1 2026, 0.07% in Q4 2025, and 0.13% in Q3 2025.